首页 | 本学科首页   官方微博 | 高级检索  
检索        

自体纯化CD34~+细胞移植治疗中/高危淋巴细胞来源恶性肿瘤的临床研究
引用本文:曾韫璟,高力,陈幸华,张曦,高蕾,张诚,文钦,孔佩艳,刘红,彭贤贵.自体纯化CD34~+细胞移植治疗中/高危淋巴细胞来源恶性肿瘤的临床研究[J].中国输血杂志,2012,25(2):120-122.
作者姓名:曾韫璟  高力  陈幸华  张曦  高蕾  张诚  文钦  孔佩艳  刘红  彭贤贵
作者单位:第三军医大学新桥医院血液科全军血液病中心,重庆,400037
基金项目:国家自然科学基金(81070388);重庆市自然科学基金重点项目(2009BA5056);第三军医大学临床科研基金(2010D249)
摘    要:目的分析自体纯化CD34+细胞移植治疗中/高危淋巴细胞来源恶性肿瘤的临床疗效。方法 10名中/高危组淋巴细胞来源恶性肿瘤患者行自体纯化CD34+细胞移植治疗,细胞分选采用cliniMACS系统。计算并统计分选纯度和CD34+细胞回收率,观察移植相关并发症及患者生存情况。结果纯化后CD34+细胞纯度为(87.79±3.73)%,回收率达到(65.74±10.37)%。10名患者全部顺利造血重建,感染发生率50%(5/10例),复发率为20%(2/10例)。结论利用CliniMACS系统进行外周血CD34+细胞分选,CD34+细胞纯度、回收率均满意,自体移植后造血功能重建顺利,近期疗效满意。

关 键 词:CD+细胞  自体  移植  肿瘤  临床疗效

Purified autologous CD34+ cell transplantation for the treatment of Medium/High Risk lymphocytic malignancies
ZENG Wenjing , GAO Li , CHENG Xinghua , ZHANG Xi , GAO Le , ZHANG Cheng , WEN Qin , KONG Peiyan , LIU Hong , PENG Xiangui.Purified autologous CD34+ cell transplantation for the treatment of Medium/High Risk lymphocytic malignancies[J].Chinese Journal of Blood Transfusion,2012,25(2):120-122.
Authors:ZENG Wenjing  GAO Li  CHENG Xinghua  ZHANG Xi  GAO Le  ZHANG Cheng  WEN Qin  KONG Peiyan  LIU Hong  PENG Xiangui
Institution:.Deparment of Hematology,Xinqiao Hospital,Third Micitary Medical Mniuersity,Chongqing 400037,China
Abstract:Objective To study the effectiveness of CD34+ selected autologous peripheral blood stem cell transplantation(APBSCT) in medium/high risk lymphocytic malignancies.Methods 10 patients received autologous CD34+ selected APBSCT,purified by CliniMACS device.The sorting purity and recovery of CD34+ cells were calculated.Transplant-related complications and prognosis were observed.Results After selection,the mean recovery of CD34+ cells was(65.74±10.37)% and the mean purity was(87.79±3.73)%.All 10 patients achieved hematopoietic recovery successfully.The rates of infectiou and relapse were 50%(5/10),and 20%(2/10),respectively.Conclusion Peripheral blood CD34+ selection and purification using CliniMACS system are effective with satisfactory purity and recovery.Hemopoietic recovery can be achieved with good short term effectiveness.
Keywords:CD34+ Cell  Autologous  Transplantation  Lymphocyte  Clinic effect
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号